The Catalyst

Most Recent Posts

11.19.14 | By Robert Zirkelbach

Patients are living longer, healthier lives thanks to biopharmaceutical innovation.  But, as evidenced by a new study released yesterday by the Tufts Center for the Study of Drug Development, the road to bringing a new FDA-approved medicine to patients is long and the costs are formidable.

11.17.14 | By Dr. John Marshall and Scott LaGanga

“Unless someone like you cares a whole awful lot, nothing is going to get better. It’s not.” Real change and progress, as Dr. Seuss suggests, starts with passionate individuals who want to make a difference. This is obvious from the dedicated researchers around the world working tirelessly to find new treatments that help patients with devastating diseases like gastrointestinal (GI) cancers.

11.14.14 | By Josephine Martin

The discovery and development of new medicines for patients is a comprehensive, data-driven process that requires years of research. At the heart of this endeavor is the clinical trial, the rigorous and highly-regulated scientific study of potential new medicines.

11.13.14 | By John Castellani

The fantastic news came yesterday that Dr. Craig Spencer, the last patient in the U.S. with Ebola, has been cured. While this development certainly inspires hope, there is still much to be done in West Africa before we can celebrate the end of this dangerous disease that has already taken nearly 5,000 lives.

11.13.14 | By Allyson Funk

This morning, PhRMA joined Morning Consult to host a panel of experts discussing where health care coverage stands now and where we need to go. The conversation was spurred by a recent poll Morning Consult produced on behalf of PhRMA that asked 1,908 registered voters their thoughts about health coverage.

phrma abcs of coverage
11.12.14 | By Allyson Funk

You’ve probably heard about the Affordable Care Act, health insurance exchanges or even the health insurance marketplace. But what does it all mean? Health insurance exchanges or the marketplace offer an alternative source to purchase health coverage if you don’t buy it on your own, receive it through your employer, or from another public program.

11.06.14 | By Holly Campbell

According to his doctor, Warren Littrel should have died several years ago. Instead, Warren recently celebrated his fifth anniversary of his diagnosis of stage IV pancreatic cancer.

11.04.14 | By Robert Zirkelbach

A national dialogue is needed around the value of new medicines and cures and the role they play in improving patient health and helping to manage long-term spending in the U.S. health care system. Unfortunately, the debate around hepatitis C has, for the most part, been twisted to the point that modern-day cures are seen as a nuisance rather than a monumental step forward in the battle against disease. (This post was updated on August 5, 2014.)

phrma i'm not average
10.30.14 | By Holly Campbell

When Matt Ellefson developed a cough, he didn’t think much of it.  He just assumed it was caused by the cold winter air, but as the weeks passed by his cough lingered. Then he began coughing up blood. Within hours of going to the ER, Matt was diagnosed with advanced non-small cell lung cancer, and the prognosis wasn’t good. With treatment, he faced a five-year survival rate of less than five percent.

10.29.14 | By Allyson Funk

When selecting health insurance coverage to suit you and your family’s needs, you may think it is safe to assume your plan will help cover the medicines prescribed by your doctor. This, however, is not always the case. Beyond making sure the treatment you need is listed on an insurance company’s list of covered medicines or formulary, there may be additional steps insurers require before you can get the medicine you were prescribed.

10.23.14 | By Allyson Funk

Would you rather take three different pills a day, following specific instructions for each, making sure you don’t forget one or just one pill a day that has the same effect?

As drug development advances, so have efforts to simplify medication delivery for patients in the form of combination therapies. These medicines contain two or more pharmaceutical ingredients in one single dose to treat a specific disease. 

access better coverage logo
10.22.14 | By Allyson Funk

When it comes to health coverage, access to health care services is not always the same. For some, out-of-pocket costs may create barriers to access and hinder adherence to needed services and treatments.

10.21.14 | By Holly Campbell

When Marina Symcox was diagnosed with gastrointestinal stromal tumor (GIST) she was given no hope. In the late 1990’s, there were no effective treatments for GIST - a rare and very deadly type of stomach cancer.  

10.20.14 | By Allyson Funk

In case you missed it, a front-page story in The New York Times this weekend told the story of Patricia Wanderlich and several other patients who, despite purchasing coverage through the health insurance exchange, or marketplace, have found high, and often combined, deductibles are a major hurdle to accessing needed care.

10.20.14 | By Dr. Bill Chin

Scientific progress is complex, time-consuming and expensive.  Researchers continue to broaden our collective understanding of disease with the hope that new findings will lead to advancements that make a real difference for patients. 

Pages